Search Results

MAIA Biotechnology, Inc. announced that Dr. Rachid Drissi, Principal Investigator at the Center for Childhood Cancer Research, Nationwide Children’s Hospital, and Associate Professor at Ohio State University, will present an abstract detailing the potency of THIO, MAIA’s telomere-targeting agent, as treatment for pediatric brain cancers at the American Association for Cancer Research Annual Meeting taking place April 5–10, 2024 in San Diego, California.

Senzime AB announced that it has secured a purchasing contract with the number one ranked children’s hospital system in the United States for its TetraGraph® quantitative neuromuscular monitoring system.

Researchers from Children’s Hospital of Philadelphia found that young children between the ages of 5 and 12 were more likely to experience a concussion from recreation and other non-sport activities, yet those injuries were not seen by specialists until days later compared with sports-related concussions in the same age group.

Eureka Therapeutics, Inc. today announced the activation of UCSF Benioff Children’s Hospitals as the first California site to join the ARYA-2 clinical trial ( NCT04634357 ).

In a landmark study, researchers from Children’s Hospital of Philadelphia found that two separate objective assessment tools and nonverbal measurements of IQ can help assess cognitive function in children with Aicardi Goutières Syndrome, allowing treatment teams to provide appropriate support and interventions.

Moligo Technologies announced today that it has signed a collaboration agreement with Nationwide Children’s Hospital to provide long, single-stranded DNA for its research into gene therapies for cystic fibrosis.

Children’s Hospital of Philadelphia announced it has entered into a Memorandum of Understanding with Sidra Medicine, a specialty healthcare organization for women, children and young people in Qatar.